Assessing Risk Factors for Relapse Following Omalizumab Discontinuation in Chronic Urticaria.

Autor: Cihanbeylerden M; Department of Pulmonology, Division of Allergy and Clinical Immunology, Hacettepe University Hospital, Ankara, Turkey., Teixeira J; Department of Dermatology and Venereology, University Hospital, Coimbra Local Health Unit, Coimbra, Portugal., Kayıkçı H; Department of Pulmonology, Division of Allergy and Clinical Immunology, Hacettepe University Hospital, Ankara, Turkey., Tüccar Ç; Department of Pulmonology, Division of Allergy and Clinical Immunology, Hacettepe University Hospital, Ankara, Turkey., Kalyoncu AF; Department of Pulmonology, Division of Allergy and Clinical Immunology, Hacettepe University Hospital, Ankara, Turkey., Damadoglu E; Department of Pulmonology, Division of Allergy and Clinical Immunology, Hacettepe University Hospital, Ankara, Turkey., Gonçalo M; Department of Dermatology and Venereology, University Hospital, Coimbra Local Health Unit, Coimbra, Portugal.; Faculty of Medicine, University of Coimbra, Coimbra, Portugal., Karakaya G; Department of Pulmonology, Division of Allergy and Clinical Immunology, Hacettepe University Hospital, Ankara, Turkey.

Publikováno v: Allergy [Allergy] 2024 Dec 26. Date of Electronic Publication: 2024 Dec 26.

Successful desensitization in a patient with recurrent anaplastic oligodendroglioma presenting with procarbazine-mediated anaphylaxis.

Autor: Kayikçi H; Faculty of Medicine, Division of Allergy and Clinical Immunology, Hacettepe University Hospital, Ankara, Turkey., Can Bostan Ö; Faculty of Medicine, Division of Allergy and Clinical Immunology, Adıyaman University Education and Training Hospital, Adıyaman, Turkey., Tuncay G; Faculty of Medicine, Division of Allergy and Clinical Immunology, Hacettepe University Hospital, Ankara, Turkey., Cihanbeylerden M; Faculty of Medicine, Division of Allergy and Clinical Immunology, Hacettepe University Hospital, Ankara, Turkey., Tüccar Ç; Faculty of Medicine, Division of Allergy and Clinical Immunology, Hacettepe University Hospital, Ankara, Turkey., Damadoglu E; Faculty of Medicine, Division of Allergy and Clinical Immunology, Hacettepe University Hospital, Ankara, Turkey., Karakaya G; Faculty of Medicine, Division of Allergy and Clinical Immunology, Hacettepe University Hospital, Ankara, Turkey., Kalyoncu AF; Faculty of Medicine, Division of Allergy and Clinical Immunology, Hacettepe University Hospital, Ankara, Turkey.

Publikováno v: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2024 Jul; Vol. 30 (5), pp. 937-940. Date of Electronic Publication: 2024 Jan 22.

Comparison of the clinical outcomes of patients with NSAID-exacerbated respiratory disease receiving aspirin or biologicals.

Autor: Tuncay G; Division of Allergy and Clinical Immunology, Hacettepe University, Ankara, Turkey., Damadoglu E; Division of Allergy and Clinical Immunology, Hacettepe University, Ankara, Turkey., Cihanbeylerden M; Division of Allergy and Clinical Immunology, Hacettepe University, Ankara, Turkey., Can Bostan O; Division of Allergy and Clinical Immunology, Hacettepe University, Ankara, Turkey., Kayıkcı H; Division of Allergy and Clinical Immunology, Hacettepe University, Ankara, Turkey., Özer S; Department of Otorhinolaryngology, Hacettepe University, Ankara, Turkey., Karakaya G; Division of Allergy and Clinical Immunology, Hacettepe University, Ankara, Turkey., Kalyoncu AF; Division of Allergy and Clinical Immunology, Hacettepe University, Ankara, Turkey.

Publikováno v: The Journal of asthma : official journal of the Association for the Care of Asthma [J Asthma] 2023 Oct; Vol. 60 (10), pp. 1885-1894. Date of Electronic Publication: 2023 Apr 21.

Sinonasal and respiratory outcomes of eosinophilic granulomatosis with polyangiitis patients receiving 100 mg mepolizumab in real-life clinical practice: 1-year follow up study.

Autor: Can Bostan O; Department of Chest Diseases, Division of Allergy and Clinical Immunology, School of Medicine, Hacettepe University, Ankara, Turkey., Duran E; Department of Internal Medicine, Division of Rheumatology, Hacettepe University School of Medicine, Ankara, Turkey.; School of Medicine, Hacettepe University, Vasculitis Research Centre, Ankara, Turkey., Tuncay G; Department of Chest Diseases, Division of Allergy and Clinical Immunology, School of Medicine, Hacettepe University, Ankara, Turkey., Cihanbeylerden M; Department of Chest Diseases, Division of Allergy and Clinical Immunology, School of Medicine, Hacettepe University, Ankara, Turkey., Karadag O; Department of Internal Medicine, Division of Rheumatology, Hacettepe University School of Medicine, Ankara, Turkey.; School of Medicine, Hacettepe University, Vasculitis Research Centre, Ankara, Turkey., Damadoglu E; Department of Chest Diseases, Division of Allergy and Clinical Immunology, School of Medicine, Hacettepe University, Ankara, Turkey., Karakaya G; Department of Chest Diseases, Division of Allergy and Clinical Immunology, School of Medicine, Hacettepe University, Ankara, Turkey., Kalyoncu AF; Department of Chest Diseases, Division of Allergy and Clinical Immunology, School of Medicine, Hacettepe University, Ankara, Turkey.

Publikováno v: The Journal of asthma : official journal of the Association for the Care of Asthma [J Asthma] 2023 May; Vol. 60 (5), pp. 931-937. Date of Electronic Publication: 2022 Sep 14.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.